Mahamaya Lifesciences Limited
Abundantia Capital sold 1,32,000 shares of Mahamaya Lifesciences Limited for ₹2.41 Cr at ₹182.50 apiece in a bulk deal.
A manufacturer and exporter of crop protection products and bioproducts, Mahamaya Lifesciences operates in the agrochemicals and pesticides sector since its incorporation in 2002. The company specializes in developing and registering formulations for crop and soil health management, serving agricultural markets through its portfolio of finest crop protection solutions designed to enhance farm productivity and sustainability.
Abundantia Capital is a foreign portfolio investor that participates as an anchor investor in Indian SME IPOs through its Abundantia Capital VCC fund vehicles. It invests across sectors including chemicals, engineering, agro, packaging, and steel.